Abstract:Background: Anxiety disorders are a category of mental disorders characterized by feelings of anxiety and fear, which include generalized anxiety disorder (GAD). Obsessive-Compulsive Disorder (OCD) used to be categorized as anxiety disorder in DSM-IV. However OCD was no longer included in anxiety disorders and came into its own category titled as Obsessive-Compulsive and Related Disorders (OCRD) in DSM-5. It will be interesting to explore is there any different biological characteristics between OCD and anxiety disorders. Brain-derived neurotrophic factor (BDNF) was a potential candidate gene in both OCD and GAD. The results of genetic association studies between BDNF and OCD have been inconsistent. BDNF plasma/serum levels in OCD have been found lower than those in healthy controls. However the heritable reason of the lowered BDNF levels was not well elucidated. The amount of studies about BDNF and GAD were relatively small. The aims of this study were to determine whether single nucleotide polymorphism Val66Met of BDNF was associated with OCD and GAD, to examine BDNF plasma levels in OCD and GAD, and to explore whether Val66Met variation influences BDNF plasma levels.Methods: We genotyped Val66Met variation in 148 OCD patients, 108 GAD patients and 99 healthy controls. Within the same sample. BDNF plasma levels were determined in 113 OCD patients, 102 GAD patients and 63 healthy controls.Results: Val66Met variation was not associated with OCD or GAD. BDNF plasma levels in OCD and GAD patients were significant lower than those in healthy controls. Val66Met variation had no influence on BDNF plasma levels. No difference was found between OCD and GAD. Results do not change no matter taking OCD and GAD as one group or separated two.Limitations: First, the sample size for genotyping was relatively small, which leaded to a low statistical power of the genetic part in this study. Second, we genotyped just one SNP in BDNF gene. Third, parts of the participants did not be assayed for BDNF plasma levels.Conclusions: Our findings support the hypothesis that BDNF is involved in the pathophysiology of mental disorders, not only OCD but also GAD. OCD and GAD patients both show lower BDNF plasma levels compared to healthy controls. The BDNF plasma levels are not associated with Val66Met variation. (C) 2015 Elsevier B.V. All rights reserved.

Genetic Variant Bdnf (val66met) Polymorphism Alters Anxiety-Related Behavior

Association Of Brain-Derived Neurotrophic Factor Genetic Val66met Polymorphism With Severity Of Depression, Efficacy Of Fluoxetine And Its Side Effects In Chinese Major Depressive Patients

Variant brain-derived neurotrophic factor Val66Met polymorphism alters vulnerability to stress and response to antidepressants

Variant BDNF Val66Met Polymorphism Affects Extinction of Conditioned Aversive Memory.

Association of BDNF Val66Met polymorphism with both baseline HRQOL scores and improvement in HRQOL scores in Chinese major depressive patients treated with fluoxetine.

Transcriptome profiling analysis of the mechanisms underlying the BDNF Val66Met polymorphism induced dysfunctions of the central nervous system

The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility: progress and controversy

BDNF val66met Polymorphism Impairs Hippocampal Long-Term Depression by Down-Regulation of 5-HT3 Receptors.

Variant Brain-Derived Neurotrophic Factor (BDNF) (met66) Alters the Intracellular Trafficking and Activity-Dependent Secretion of Wild-Type BDNF in Neurosecretory Cells and Cortical Neurons

Behavioral phenotyping of a rat model of the BDNF Val66Met polymorphism reveals selective impairment of fear memory

BDNF Val66Met Polymorphism and Anxiety/depression Symptoms in Schizophrenia in a Chinese Han Population.

The BDNF Val66Met Gene Polymorphism is Associated with Increased Alexithymic and Anticipatory Anxiety in Patients with Panic Disorder.

The BDNF Val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function

Brain Derived Neurotrophic Factor (BDNF) Gene Variants and Alzheimer's Disease, Affective Disorders, Posttraumatic Stress Disorder, Schizophrenia, and Substance Dependence

Brain-derived neurotrophic factor Val66Met genotype modulates amygdala habituation

The BDNF Val66Met polymorphism modulates the generalization of cued fear responses to a novel context

BDNF Val66Met Polymorphism and Plasma Levels in Chinese Han Population with Obsessive-Compulsive Disorder and Generalized Anxiety Disorder.

Amygdala-dependent fear conditioning in humans is modulated by the BDNFval66met polymorphism.

PTSD Risk is Associated with BDNF Val66Met and BDNF Overexpression

Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice.

BDNFVal66met polymorphism: a potential bridge between depression and thrombosis